FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104498045> ?p ?o ?g. }

• W2104498045 endingPage "e80302" @default.
• W2104498045 startingPage "e80302" @default.
• W2104498045 abstract "Background In pulmonary tuberculosis (PTB), morbidity during treatment and residual pulmonary disability can be under-estimated. Methods Among adults with smear-positive PTB at an outpatient clinic in Papua, Indonesia, we assessed morbidity at baseline and during treatment, and 6-month residual disability, by measuring functional capacity (six-minute walk test [6MWT] and pulmonary function), quality of life (St George’s Respiratory Questionnaire [SGRQ]) and Adverse Events ([AE]: new symptoms not present at outset). Results were compared with findings in locally-recruited volunteers. Results 200 PTB patients and 40 volunteers were enrolled. 6WMT was 497m (interquartile range 460-529) in controls versus 408m (IQR 346-450) in PTB patients at baseline (p<0.0001) and 470m (IQR 418-515) in PTB patients after 6 months (p=0.02 versus controls). SGRQ total score was 0 units (IQR 0-2.9) in controls, versus 36.9 (27.4-52.8) in PTB patients at baseline (p<0.0001) and 4.3 (1.7-8.8) by 6 months (p<0.0001). Mean percentage of predicted FEV1 was 92% (standard deviation 19.9) in controls, versus 63% (19.4) in PTB patients at baseline (p<0.0001) and 71% (17.5) by 6 months (p<0.0001). After 6 months, 27% of TB patients still had at least moderate-severe pulmonary function impairment, and 57% still had respiratory symptoms, despite most achieving ‘successful’ treatment outcomes, and reporting good quality of life. More-advanced disease at baseline (longer illness duration, worse baseline X-ray) and HIV positivity predicted residual disability. AE at any time during treatment were common: itch 59%, arthralgia 58%, headache 40%, nausea 33%, vomiting 16%. Conclusion We found high 6-month residual pulmonary disability and high AE rates. Although PTB treatment is highly successful, the extent of morbidity during treatment and residual impairment could be overlooked if not specifically sought. Calculations of PTB-related burden of disease should acknowledge that TB-related morbidity does not stop at 6 months. Early case detection and treatment are key in minimising residual impairment." @default.
• W2104498045 created "2016-06-24" @default.
• W2104498045 creator A5010389872 @default.
• W2104498045 creator A5020224633 @default.
• W2104498045 creator A5027643661 @default.
• W2104498045 creator A5030502584 @default.
• W2104498045 creator A5032095213 @default.
• W2104498045 creator A5043841190 @default.
• W2104498045 creator A5068755589 @default.
• W2104498045 creator A5069443424 @default.
• W2104498045 creator A5074616017 @default.
• W2104498045 date "2013-11-29" @default.
• W2104498045 modified "2023-10-14" @default.
• W2104498045 title "High Morbidity during Treatment and Residual Pulmonary Disability in Pulmonary Tuberculosis: Under-Recognised Phenomena" @default.
• W2104498045 cites W1981015386 @default.
• W2104498045 cites W1985710478 @default.
• W2104498045 cites W2001654461 @default.
• W2104498045 cites W2016162827 @default.
• W2104498045 cites W2025655074 @default.
• W2104498045 cites W2055314405 @default.
• W2104498045 cites W2062449235 @default.
• W2104498045 cites W2064727915 @default.
• W2104498045 cites W2067650891 @default.
• W2104498045 cites W2074003419 @default.
• W2104498045 cites W2083436606 @default.
• W2104498045 cites W2096932171 @default.
• W2104498045 cites W2097950056 @default.
• W2104498045 cites W2098765769 @default.
• W2104498045 cites W2098793988 @default.
• W2104498045 cites W2104902995 @default.
• W2104498045 cites W2108310467 @default.
• W2104498045 cites W2108458974 @default.
• W2104498045 cites W2109028417 @default.
• W2104498045 cites W2112348327 @default.
• W2104498045 cites W2114982679 @default.
• W2104498045 cites W2124879124 @default.
• W2104498045 cites W2135989318 @default.
• W2104498045 cites W2136190705 @default.
• W2104498045 cites W2136720849 @default.
• W2104498045 cites W2141887601 @default.
• W2104498045 cites W2145726869 @default.
• W2104498045 cites W2154396724 @default.
• W2104498045 cites W2157430144 @default.
• W2104498045 cites W2159393897 @default.
• W2104498045 cites W2160056424 @default.
• W2104498045 cites W2245573514 @default.
• W2104498045 doi "https://doi.org/10.1371/journal.pone.0080302" @default.
• W2104498045 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3843655" @default.
• W2104498045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24312209" @default.
• W2104498045 hasPublicationYear "2013" @default.
• W2104498045 type Work @default.
• W2104498045 sameAs 2104498045 @default.
• W2104498045 citedByCount "63" @default.
• W2104498045 countsByYear W21044980452015 @default.
• W2104498045 countsByYear W21044980452016 @default.
• W2104498045 countsByYear W21044980452017 @default.
• W2104498045 countsByYear W21044980452018 @default.
• W2104498045 countsByYear W21044980452019 @default.
• W2104498045 countsByYear W21044980452020 @default.
• W2104498045 countsByYear W21044980452021 @default.
• W2104498045 countsByYear W21044980452022 @default.
• W2104498045 countsByYear W21044980452023 @default.
• W2104498045 crossrefType "journal-article" @default.
• W2104498045 hasAuthorship W2104498045A5010389872 @default.
• W2104498045 hasAuthorship W2104498045A5020224633 @default.
• W2104498045 hasAuthorship W2104498045A5027643661 @default.
• W2104498045 hasAuthorship W2104498045A5030502584 @default.
• W2104498045 hasAuthorship W2104498045A5032095213 @default.
• W2104498045 hasAuthorship W2104498045A5043841190 @default.
• W2104498045 hasAuthorship W2104498045A5068755589 @default.
• W2104498045 hasAuthorship W2104498045A5069443424 @default.
• W2104498045 hasAuthorship W2104498045A5074616017 @default.
• W2104498045 hasBestOaLocation W21044980451 @default.
• W2104498045 hasConcept C119060515 @default.
• W2104498045 hasConcept C126322002 @default.
• W2104498045 hasConcept C142724271 @default.
• W2104498045 hasConcept C159110408 @default.
• W2104498045 hasConcept C197934379 @default.
• W2104498045 hasConcept C2779951463 @default.
• W2104498045 hasConcept C2781069245 @default.
• W2104498045 hasConcept C2908628106 @default.
• W2104498045 hasConcept C534529494 @default.
• W2104498045 hasConcept C71924100 @default.
• W2104498045 hasConcept C75603125 @default.
• W2104498045 hasConceptScore W2104498045C119060515 @default.
• W2104498045 hasConceptScore W2104498045C126322002 @default.
• W2104498045 hasConceptScore W2104498045C142724271 @default.
• W2104498045 hasConceptScore W2104498045C159110408 @default.
• W2104498045 hasConceptScore W2104498045C197934379 @default.
• W2104498045 hasConceptScore W2104498045C2779951463 @default.
• W2104498045 hasConceptScore W2104498045C2781069245 @default.
• W2104498045 hasConceptScore W2104498045C2908628106 @default.
• W2104498045 hasConceptScore W2104498045C534529494 @default.
• W2104498045 hasConceptScore W2104498045C71924100 @default.
• W2104498045 hasConceptScore W2104498045C75603125 @default.
• W2104498045 hasIssue "11" @default.
• W2104498045 hasLocation W21044980451 @default.
• W2104498045 hasLocation W21044980452 @default.

• next